IBDEI0UV ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14994,0)
 ;;=250.60^^81^937^7
 ;;^UTILITY(U,$J,358.3,14994,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14994,1,4,0)
 ;;=4^250.60
 ;;^UTILITY(U,$J,358.3,14994,1,5,0)
 ;;=5^DM Type II Dm with Neuropathy
 ;;^UTILITY(U,$J,358.3,14994,2)
 ;;=^267841^357.2
 ;;^UTILITY(U,$J,358.3,14995,0)
 ;;=250.70^^81^937^8
 ;;^UTILITY(U,$J,358.3,14995,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14995,1,4,0)
 ;;=4^250.70
 ;;^UTILITY(U,$J,358.3,14995,1,5,0)
 ;;=5^DM Type II Dm with Peripheral Vasc Dis
 ;;^UTILITY(U,$J,358.3,14995,2)
 ;;=^267843^443.81
 ;;^UTILITY(U,$J,358.3,14996,0)
 ;;=250.01^^81^937^4
 ;;^UTILITY(U,$J,358.3,14996,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14996,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,14996,1,5,0)
 ;;=5^DM Type I DM W/O Complications
 ;;^UTILITY(U,$J,358.3,14996,2)
 ;;=^33586
 ;;^UTILITY(U,$J,358.3,14997,0)
 ;;=272.0^^81^937^22
 ;;^UTILITY(U,$J,358.3,14997,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14997,1,4,0)
 ;;=4^272.0
 ;;^UTILITY(U,$J,358.3,14997,1,5,0)
 ;;=5^Hypercholesterolemia, Pure
 ;;^UTILITY(U,$J,358.3,14997,2)
 ;;=Hypercholesterolemia, Pure^59973
 ;;^UTILITY(U,$J,358.3,14998,0)
 ;;=272.1^^81^937^28
 ;;^UTILITY(U,$J,358.3,14998,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14998,1,4,0)
 ;;=4^272.1
 ;;^UTILITY(U,$J,358.3,14998,1,5,0)
 ;;=5^Hypertriglyceridemia, Pure
 ;;^UTILITY(U,$J,358.3,14998,2)
 ;;=Hypertriglyceridemia, Pure^101303
 ;;^UTILITY(U,$J,358.3,14999,0)
 ;;=272.2^^81^937^24
 ;;^UTILITY(U,$J,358.3,14999,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14999,1,4,0)
 ;;=4^272.2
 ;;^UTILITY(U,$J,358.3,14999,1,5,0)
 ;;=5^Hyperlipidemia, Mixed
 ;;^UTILITY(U,$J,358.3,14999,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,15000,0)
 ;;=275.42^^81^937^21
 ;;^UTILITY(U,$J,358.3,15000,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15000,1,4,0)
 ;;=4^275.42
 ;;^UTILITY(U,$J,358.3,15000,1,5,0)
 ;;=5^Hypercalcemia
 ;;^UTILITY(U,$J,358.3,15000,2)
 ;;=^59932
 ;;^UTILITY(U,$J,358.3,15001,0)
 ;;=275.41^^81^937^29
 ;;^UTILITY(U,$J,358.3,15001,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15001,1,4,0)
 ;;=4^275.41
 ;;^UTILITY(U,$J,358.3,15001,1,5,0)
 ;;=5^Hypocalcemia
 ;;^UTILITY(U,$J,358.3,15001,2)
 ;;=^60542
 ;;^UTILITY(U,$J,358.3,15002,0)
 ;;=276.7^^81^937^23
 ;;^UTILITY(U,$J,358.3,15002,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15002,1,4,0)
 ;;=4^276.7
 ;;^UTILITY(U,$J,358.3,15002,1,5,0)
 ;;=5^Hyperkalemia
 ;;^UTILITY(U,$J,358.3,15002,2)
 ;;=^60042
 ;;^UTILITY(U,$J,358.3,15003,0)
 ;;=275.2^^81^937^19
 ;;^UTILITY(U,$J,358.3,15003,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15003,1,4,0)
 ;;=4^275.2
 ;;^UTILITY(U,$J,358.3,15003,1,5,0)
 ;;=5^Hyper Or Hypomagnesemia
 ;;^UTILITY(U,$J,358.3,15003,2)
 ;;=^35626
 ;;^UTILITY(U,$J,358.3,15004,0)
 ;;=276.0^^81^937^25
 ;;^UTILITY(U,$J,358.3,15004,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15004,1,4,0)
 ;;=4^276.0
 ;;^UTILITY(U,$J,358.3,15004,1,5,0)
 ;;=5^Hypernatremia
 ;;^UTILITY(U,$J,358.3,15004,2)
 ;;=^60144
 ;;^UTILITY(U,$J,358.3,15005,0)
 ;;=276.1^^81^937^32
 ;;^UTILITY(U,$J,358.3,15005,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15005,1,4,0)
 ;;=4^276.1
 ;;^UTILITY(U,$J,358.3,15005,1,5,0)
 ;;=5^Hyponatremia
 ;;^UTILITY(U,$J,358.3,15005,2)
 ;;=Hyponatremia^60722
 ;;^UTILITY(U,$J,358.3,15006,0)
 ;;=275.3^^81^937^20
 ;;^UTILITY(U,$J,358.3,15006,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15006,1,4,0)
 ;;=4^275.3
 ;;^UTILITY(U,$J,358.3,15006,1,5,0)
 ;;=5^Hyper Or Hypophosphatemia
 ;;^UTILITY(U,$J,358.3,15006,2)
 ;;=^93796
 ;;^UTILITY(U,$J,358.3,15007,0)
 ;;=240.0^^81^937^14
 ;;^UTILITY(U,$J,358.3,15007,1,0)
 ;;=^358.31IA^5^2
 ;;
 ;;$END ROU IBDEI0UV
